(Q38523551)

3 September 2017

title

GABAergic neuronal subtypes in the human frontal cortex--development and deficits in schizophrenia (English)

1 reference

3 September 2017

0 references

0 references

Reynolds GP

1

1 reference

3 September 2017

Beasley CL

series ordinal

2

1 reference

3 September 2017

publication date

1 July 2001

1 reference

Journal of Chemical Neuroanatomy

3 September 2017

published in

1 reference

3 September 2017

volume

22

1 reference

3 September 2017

issue

1-2

1 reference

3 September 2017

page(s)

95-100

1 reference

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

VBR in schizophrenia: relationship to family history of psychosis and season of birth

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

The early origins of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Obstetric complications in schizophrenic parents

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

GABAergic hippocampal neurons resistant to ischemia-induced neuronal death contain the Ca2(+)-binding protein parvalbumin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Neurotransmitter systems in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Ontogeny of the calcium binding protein parvalbumin in the rat nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Family history and brain morphology in schizophrenia: an MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900113-2

7 January 2021

10.1016/S0891-0618(01)00113-2

Identifiers

DOI

1 reference

3 September 2017

1 reference